Larimar Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5171251003
USD
3.07
0.41 (15.41%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryLarimar Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
15.41%
-0.51%
1W
27.39%
-1.37%
1M
44.81%
0.35%
YTD
-20.67%
0.54%
1Y
-68.09%
13.99%
3Y
18.08%
66.39%
5Y
-78.8%
77.77%
10Y
-78.8%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
6.6%
0%
6.6%
6 Months
-53.27%
0%
-53.27%
1 Year
-68.09%
0%
-68.09%
2 Years
-15.89%
0%
-15.89%
3 Years
18.08%
0%
18.08%
4 Years
-63.41%
0%
-63.41%
5 Years
-78.8%
0%
-78.8%

Larimar Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary